A detailed history of Cordatus Wealth Management LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Cordatus Wealth Management LLC holds 5,472 shares of NVO stock, worth $478,088. This represents 0.23% of its overall portfolio holdings.

Number of Shares
5,472
Previous 5,472 -0.0%
Holding current value
$478,088
Previous $781,000 16.52%
% of portfolio
0.23%
Previous 0.29%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 18, 2024

BUY
$122.71 - $146.91 $671,469 - $803,891
5,472 New
5,472 $781,000
Q2 2023

Jul 14, 2023

BUY
$155.98 - $172.65 $480,418 - $531,762
3,080 New
3,080 $498,000
Q3 2022

Oct 25, 2022

SELL
$95.28 - $116.93 $523,087 - $641,945
-5,490 Closed
0 $0
Q2 2022

Aug 24, 2022

SELL
$103.24 - $121.81 $276,373 - $326,085
-2,677 Reduced 32.78%
5,490 $612,000
Q1 2022

May 06, 2022

BUY
$93.1 - $112.54 $760,347 - $919,114
8,167 New
8,167 $907,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Cordatus Wealth Management LLC Portfolio

Follow Cordatus Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cordatus Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cordatus Wealth Management LLC with notifications on news.